OPHTHALMIC COMPOSITION
To provide an ophthalmic composition that contains high-concentration chondroitin sulfate or a salt thereof and an imidazoline compound or a salt thereof but has reduced variation in an amount of instillation.SOLUTION: An ophthalmic composition contains (A) at least one selected from a group consist...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English Japanese |
| Published |
30.11.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | To provide an ophthalmic composition that contains high-concentration chondroitin sulfate or a salt thereof and an imidazoline compound or a salt thereof but has reduced variation in an amount of instillation.SOLUTION: An ophthalmic composition contains (A) at least one selected from a group consisting of chondroitin sulfate and a salt thereof, (B) an imidazoline compound and a salt thereof, and (C) an antihistamine, a content of the component (A) being 0.7-1.2 w/v% relative to a total amount of the ophthalmic composition.SELECTED DRAWING: None
【課題】高濃度のコンドロイチン硫酸又はその塩とイミダゾリン化合物又はその塩とを含有しながら、滴下量のばらつきが抑制された眼科組成物を提供すること。【解決手段】（Ａ）コンドロイチン硫酸及びその塩からなる群より選択される少なくとも１種と、（Ｂ）イミダゾリン化合物及びその塩と、（Ｃ）抗ヒスタミン剤と、を含有する眼科組成物であって、（Ａ）成分の含有量が該眼科組成物の総量を基準として０．７～１．２ｗ／ｖ％である、眼科組成物。【選択図】なし |
|---|---|
| AbstractList | To provide an ophthalmic composition that contains high-concentration chondroitin sulfate or a salt thereof and an imidazoline compound or a salt thereof but has reduced variation in an amount of instillation.SOLUTION: An ophthalmic composition contains (A) at least one selected from a group consisting of chondroitin sulfate and a salt thereof, (B) an imidazoline compound and a salt thereof, and (C) an antihistamine, a content of the component (A) being 0.7-1.2 w/v% relative to a total amount of the ophthalmic composition.SELECTED DRAWING: None
【課題】高濃度のコンドロイチン硫酸又はその塩とイミダゾリン化合物又はその塩とを含有しながら、滴下量のばらつきが抑制された眼科組成物を提供すること。【解決手段】（Ａ）コンドロイチン硫酸及びその塩からなる群より選択される少なくとも１種と、（Ｂ）イミダゾリン化合物及びその塩と、（Ｃ）抗ヒスタミン剤と、を含有する眼科組成物であって、（Ａ）成分の含有量が該眼科組成物の総量を基準として０．７～１．２ｗ／ｖ％である、眼科組成物。【選択図】なし |
| Author | MATSUMOTO SACHIKO NAKADA ATSUKO |
| Author_xml | – fullname: MATSUMOTO SACHIKO – fullname: NAKADA ATSUKO |
| BookMark | eNrjYmDJy89L5WQQ8w_wCPFw9PH1dFZw9vcN8A_2DPH09-NhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGRkaG5maWxgaOxkQpAgDUuCGM |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 眼科組成物 |
| ExternalDocumentID | JP2022176930A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_JP2022176930A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:41:06 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Japanese |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_JP2022176930A3 |
| Notes | Application Number: JP20220081191 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221130&DB=EPODOC&CC=JP&NR=2022176930A |
| ParticipantIDs | epo_espacenet_JP2022176930A |
| PublicationCentury | 2000 |
| PublicationDate | 20221130 |
| PublicationDateYYYYMMDD | 2022-11-30 |
| PublicationDate_xml | – month: 11 year: 2022 text: 20221130 day: 30 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | ROHTO PHARMACEUT CO LTD |
| RelatedCompanies_xml | – name: ROHTO PHARMACEUT CO LTD |
| Score | 3.5671518 |
| Snippet | To provide an ophthalmic composition that contains high-concentration chondroitin sulfate or a salt thereof and an imidazoline compound or a salt thereof but... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | OPHTHALMIC COMPOSITION |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221130&DB=EPODOC&locale=&CC=JP&NR=2022176930A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTNNS7NMNErWNbFMs9Q1STY21E00TTLRTUkC9sSMUg0NDFLAq3z9zDxCTbwiTCOYGLJhe2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bATszhgbqLk42boG-Lv4O6s5O9t6Baj5BUHkwPf-OTIzsALb0eag7OAa5gTallKAXKe4CTKwBQCNyysRYmDKShRm4HSGXb0mzMDhC53xBjKhma9YhEHMP8AjxMPRBxhwCs7-vgH-wZ6g8SVRBiU31xBnD12gBfFw78R7BSA5xliMgQXYz0-VYFAwTUsxM0oyNUs0S7QwSUxJSzJINTZMTjQ3NUsxNrVMTZJkkMZjkBReWWkGLhAPcmahDANLSVFpqiywNi1JkgOHAgB6UnV2 |
| link.rule.ids | 230,309,783,888,25576,76882 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsd0fgyRvhX7lbo-FNnSlq72I2iVvY2kH6CCDlfx3zfNOt3T3kIOLsnB5fK73AfAjYnK0qJaJhtWaclGpqsyRcyQc8aRmFaoipKLKN_Y9J-NYIZmLXhf58KIOqE_ojgi16iM63sl7uvFvxPLEbGVy1v2yqc-773UdqQGHWsczuiK5ExslyROgiWM7YBI8eOKJvr-jXdgl7-xR3W7A_dlUqelLDZtincIe4Sz-6iOoPVGu9DB69ZrXdiPmh9vPmyUb3kMvYT4qT8OueCGOIlI8jSt_UsncO25KfZlvsD87zjzgGxsRu9Bm-P8og9DVOamxpBJTToyaF4ypdDVjN4hM9eRVbBTGGxhdLaVegUdP43CeTiNHwZwUFNW9QvPoV19fRcX3LJW7FJI5Bcj6nhm |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=OPHTHALMIC+COMPOSITION&rft.inventor=MATSUMOTO+SACHIKO&rft.inventor=NAKADA+ATSUKO&rft.date=2022-11-30&rft.externalDBID=A&rft.externalDocID=JP2022176930A |